Loading…
Evonik entered into a long-term supply agreement with Phathom Pharmaceuticals to produce commercial quantities of the drug substance vonoprazan at its sites in Tippecanoe, Indiana, USA and Dossenheim, Germany. The agreement was announced on October 10, 2022.